G226, a Novel Epipolythiodioxopiperazine Derivative, Induces Autophagy and Caspase-Dependent Apoptosis in Human Breast Cancer Cells in Vitro

Peng-xing He,Yong-sheng Che,Qiao-jun He,Yi Chen,Jian Ding
DOI: https://doi.org/10.1038/aps.2014.47
2014-01-01
Abstract:Aim: To investigate the effects of G226, a novel epipolythiodioxopiperazine derivative, on human breast cancer cells in vitro , and to explore its anticancer mechanisms. Methods: A panel of human breast cancer cell lines (MDA-MB-231, MDA-MB-468, MCF-7, ZR-75-30, BT474, BT549, SK-BR-3, T47D and HBL100) was examined. Cell proliferation was measured using sulforhodamine B assay, and cell apoptosis was detected with flow cytometry and caspase activity assay. Western blotting, immunofluorescence and targeted gene knockdowns were used to study autophagy in the cells. Results: G226 suppressed proliferation of the 9 breast cancer cell lines with a mean IC 50 value of 48.5 nmol/L (the mean IC 50 value of adriamycin, a reference compound, was 170.6 nmol/L). G226 induced dose-dependent apoptosis of MDA-MB-231 and MCF-7 cells, accompanied by markedly increased activities of caspase-8 and caspase-3/7, which were abolished by caspase inhibitors zVAD or zIETD. G226 also induced mitochondrial outer membrane permeabilization, resulted in the caspase-9 activation. Moreover, G226 dose-dependently enhanced the autophagy marker LC3-II and autophagy substrate p62 accumulation in the cells, which were co-localized with caspase-8. Silencing of p62 or LC3 partially diminished caspase-8 and subsequent caspase-3 activation. LC3 silencing partially reversed G226-induced apoptosis, but p62 silencing elicited a subtle effect on G226-induced apoptosis. Conclusion: The novel epipolythiodioxopiperazine derivative G226 exerts potent anticancer action against human breast cancer cells in vitro , via triggering autophagy and caspase-dependent apoptosis.
What problem does this paper attempt to address?